The Role of Staging Laparoscopy in Primary Gall Bladder Cancer—An Analysis of 409 Patients
Authors:
- Anil K. AgarwalAAAnil K. Agarwal
- Raja KalayarasanRKRaja Kalayarasan
- Amit JavedAJAmit Javed
- Nikhil GuptaNGNikhil Gupta
- Hirdaya H. NagHNHirdaya H. Nag
- 1 August 2013
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 258 (2) , 318-323
Abstract
To evaluate the role of staging laparoscopy (SL) in the management of gallbladder cancer (GBC). A prospective study of primary GBC patients between May 2006 and December 2011. The SL was performed using an umbilical port with a 30-degree telescope. Early GBC included clinical stage T1/T2. A detectable lesion (DL) was defined as one that could be detected on SL alone, without doing any dissection or using laparoscopic ultrasound (surface liver metastasis and peritoneal deposits). Other metastatic and locally advanced unresectable disease qualified as undetectable lesions (UDL). Of the 409 primary GBC patients who underwent SL, 95 had disseminated disease [(surface liver metastasis (n = 29) and peritoneal deposits (n = 66)]. The overall yield of SL was 23.2% (95/409). Of the 314 patients who underwent laparotomy, an additional 75 had unresectable disease due to surface liver metastasis (n = 5), deep parenchymal liver metastasis (n = 4), peritoneal deposits (n = 1), nonlocoregional lymph nodes (n = 47), and locally advanced unresectable disease (n = 18), that is, 6-DL and 69-UDL. The accuracy of SL for detecting unresectable disease and DL was 55.9% (95/170) and 94.1% (95/101), respectively. Compared with early GBC, the yield was significantly higher in locally advanced tumors (n = 353) [25.2% (89/353) vs 10.7% (6/56), P = 0.02]. However, the accuracy in detecting unresectable disease and a DL in locally advanced tumors was similar to early GBC [56.0%, (89/159) and 94.1%, (89/95) vs 54.6% (6/11) and 100% (6/6), P = 1.00]. In the present series with an overall resectability rate of 58.4%, SL identified 94.1% of the DLs and thereby obviated a nontherapeutic laparotomy in 55.9% of patients with unresectable disease and 23.2% of overall GBC patients. It had a higher yield in locally advanced tumors than in early-stage tumors; however, the accuracy in detecting unresectable disease and a DL were similar.Keywords
This publication has 18 references indexed in Scilit:
- Gallbladder Cancer Involving the Extrahepatic Bile Duct is Worthy of ResectionAnnals of Surgery, 2011
- The role of staging laparoscopy for intraabdominal cancers: an evidence-based reviewSurgical Endoscopy, 2008
- Surgical Management of Gallbladder Carcinoma: A ReviewJournal of Gastrointestinal Surgery, 2007
- Utility of staging laparoscopy in subsets of biliary cancersSurgical Endoscopy, 2006
- Laparoscopic Staging in Gallbladder CancerDigestive Surgery, 2005
- The Role of Staging Laparoscopy in Hepatobiliary Malignancy: Prospective Analysis of 401 CasesAnnals of Surgical Oncology, 2003
- Role of laparoscopy in the evaluation of biliary tract cancerSurgical Oncology Clinics of North America, 2002
- Staging Laparoscopy in Patients With Extrahepatic Biliary CarcinomaAnnals of Surgery, 2002
- Staging laparoscopy and laparoscopic ultrasonography in more than 400 patients with upper gastrointestinal carcinoma11No competing interests declared.Journal of the American College of Surgeons, 1999
- Surgical Treatment of 724 Carcinomas of the Gallbladder Results of the French Surgical Association SurveyAnnals of Surgery, 1994